Clinical trials
Terminated Sepsis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 9 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 11 |
| 2021 | 10 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 117 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ohio State University | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| National Taiwan University Hospital | 3 |
| Christiana Care Health Services | 2 |
| The University of Texas Health Science Center, Houston | 2 |
| UMC Utrecht | 2 |
| University Hospital, Limoges | 2 |
| University Hospital, Rouen | 2 |
| Vanderbilt University | 2 |
| Wake Forest University Health Sciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 117 |
| Shock, Septic | 32 |
| Infections | 9 |
| Shock | 9 |
| Critical Illness | 7 |
| Systemic Inflammatory Response Syndrome | 7 |
| Acute Kidney Injury | 6 |
| Multiple Organ Failure | 6 |
| Bacteremia | 5 |
| Inflammation | 5 |
Trials
Showing 76 to 100 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.